Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament composition for treating male climacteric syndrome and delaying age

An anti-aging and composition technology, applied in the field of traditional Chinese medicine compositions, can solve the problems of rare traditional Chinese medicine preparations for the prevention and treatment of male menopause diseases, difficult adjustment of dosage and use time, etc. Effect

Active Publication Date: 2009-06-24
HANSHENGTANG PHARMA
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the past, androgen supplementation therapy (TST) was generally used, but the dosage and time of use were not easy to adjust. In recent years, more attention has been paid to andropause-related diseases, which provides an opportunity for Chinese medicine to study andropause health
[0005] The prevention and treatment research of traditional Chinese medicine is mostly based on liver and kidney yin deficiency, deficiency of fire and inflammation; liver depression and spleen deficiency, essence and blood disorders; However, it is rare to find traditional Chinese medicine preparations dedicated to the prevention and treatment of male menopausal diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament composition for treating male climacteric syndrome and delaying age
  • Medicament composition for treating male climacteric syndrome and delaying age
  • Medicament composition for treating male climacteric syndrome and delaying age

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0137] Embodiment 1: the preparation of capsule

[0138] Epimedium 35kg Rhodiola rosea 10kg Seabuckthorn 5kg Yizhiren 5kg

[0139] Yam 5kg Ginkgo 2.5kg Ganoderma lucidum spore powder 2.5kg Polygonatum 5kg

[0140] Rehmannia glutinosa 5kg Goji berries 10kg Leek seeds 5kg Astragalus 10kg

[0141] The above-mentioned raw materials are taken, added with conventional auxiliary materials, boiled in water, alcoholized, dried and pulverized according to the conventional process to make powder into capsules.

Embodiment 2

[0142] Embodiment 2: the preparation of capsule

[0143] Epimedium 25kg Rhodiola 14kg Seabuckthorn 3kg Yizhiren 8kg

[0144] Yam 4kg Ginkgo 4kg Ganoderma lucidum spore powder 2kg Polygonatum 7kg

[0145] Rehmannia glutinosa 2.5kg Lycium barbarum 13kg Leek seeds 3.5kg Astragalus 6kg

[0146] The above-mentioned raw materials are taken, added with conventional auxiliary materials, boiled in water, alcoholized, dried and pulverized according to the conventional process to make powder into capsules.

Embodiment 3

[0147] Embodiment 3: the preparation of capsule

[0148] Epimedium 45kg Rhodiola rosea 6kg Seabuckthorn 8kg Yizhiren 3kg

[0149] Yam 7kg Ginkgo 2kg Ganoderma lucidum spore powder 4kg Polygonatum 4kg

[0150] Rehmannia glutinosa 6kg Goji berries 7kg Leek seeds 2.5kg Astragalus 14kg

[0151] The above-mentioned raw materials are taken, added with conventional auxiliary materials, boiled in water, alcoholized, dried and pulverized according to the conventional process to make powder into capsules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating male menopause syndrome and delaying senility. The pharmaceutical composition is prepared from epimedium, rhodiola root, sea buckthorne, fructus alpiniae oxyphyllae, Chinese yam, ginkgo seed, ganoderma lucidum spore powder, rhizome polygonati, prepared rhizome of rehmannia, medlar, Chinese chive seeds, and hoantchy root. The raw material drugs are added with the prior accessories, and prepared into various clinically acceptable dosage forms by the prior process, such as capsule, granule, tablet, oral liquid preparation, and the like. The invention also provides application of the pharmaceutical composition to prepare medicaments for treating the male menopause syndrome and delaying the senility, enhancing immune function, and alleviating fatigue.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a medicinal composition for treating male climacteric syndrome, delaying aging, enhancing immunity and relieving fatigue. Background technique [0002] As people grow older, they show physiological phenomena in different periods. Andropause is a relatively long and unavoidable age stage transitioning to old age. The obvious physiological changes in this period are from vigorous reproductive function to weakening. Some physiological changes or subjective symptoms are not very obvious, so the physiological changes and related diseases of male menopause are easily overlooked. With the progress of society and the acceleration of the pace of work and life, the symptoms and diseases related to male menopause are on the rise, such as cardiovascular disease, diabetes, and Alzheimer's disease, which reminds the urgency of strengthening the care of menopausal men. [0003] Dur...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9062A61K9/08A61K9/10A61K9/16A61K9/19A61K9/20A61K9/48A61P15/12A61P37/04A61P39/06
Inventor 刘敏如李嘉音
Owner HANSHENGTANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com